Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 854

1.

Mammalian Pericardium-Based Bioprosthetic Materials in Xenotransplantation and Tissue Engineering.

Grebenik ЕA, Gafarova ER, Istranov LP, Istranova ЕV, Ma X, Xu J, Guo W, Atala A, Timashev PS.

Biotechnol J. 2020 Feb 20:e1900334. doi: 10.1002/biot.201900334. [Epub ahead of print] Review.

PMID:
32077589
2.

Re: High-Fat Diet Fuels Prostate Cancer Progression by Rewiring the Metabolome and Amplifying the MYC Program.

Atala A.

J Urol. 2020 Feb 12:101097JU000000000000078102. doi: 10.1097/JU.0000000000000781.02. [Epub ahead of print] No abstract available.

PMID:
32073994
3.

Re: 5-Methylcytosine Promotes Pathogenesis of Bladder Cancer through Stabilizing mRNAs.

Atala A.

J Urol. 2020 Feb 12:101097JU0000000000000781. doi: 10.1097/JU.0000000000000781. [Epub ahead of print] No abstract available.

PMID:
32073983
4.

Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression.

Atala A.

J Urol. 2020 Feb 12:101097JU000000000000078101. doi: 10.1097/JU.0000000000000781.01. [Epub ahead of print] No abstract available.

PMID:
32073976
5.

Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery.

Almeida-Porada G, Atala AJ, Porada CD.

Mol Ther Methods Clin Dev. 2020 Jan 22;16:204-224. doi: 10.1016/j.omtm.2020.01.005. eCollection 2020 Mar 13. Review.

6.

Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.

Rajan SAP, Aleman J, Wan M, Zarandi NP, Nzou G, Murphy S, Bishop CE, Sadri-Ardekani H, Shupe T, Atala A, Hall AR, Skardal A.

Acta Biomater. 2020 Feb 14. pii: S1742-7061(20)30094-5. doi: 10.1016/j.actbio.2020.02.015. [Epub ahead of print]

PMID:
32068138
7.

A Cocktail of Growth Factors Released from Heparin Hyaluronic-Acid Hydrogel Promotes the Myogenic Potential of Human Urine-Derived Stem Cells in Vivo.

Liu G, Wu R, Yang B, Shi Y, Deng C, Atala A, Mou S, Criswell T, Zhang Y.

Acta Biomater. 2020 Feb 7. pii: S1742-7061(20)30083-0. doi: 10.1016/j.actbio.2020.02.005. [Epub ahead of print]

PMID:
32044457
8.

CRISPR/Cas9 increases mitotic gene conversion in human cells.

Javidi-Parsijani P, Lyu P, Makani V, Sarhan WM, Yoo KW, El-Korashi L, Atala A, Lu B.

Gene Ther. 2020 Feb 4. doi: 10.1038/s41434-020-0126-z. [Epub ahead of print]

PMID:
32020049
9.

Reno-protection of Urine-derived Stem Cells in A Chronic Kidney Disease Rat Model Induced by Renal Ischemia and Nephrotoxicity.

Zhang C, George SK, Wu R, Thakker PU, Abolbashari M, Kim TH, Ko IK, Zhang Y, Sun Y, Jackson J, Lee SJ, Yoo JJ, Atala A.

Int J Biol Sci. 2020 Jan 1;16(3):435-446. doi: 10.7150/ijbs.37550. eCollection 2020.

10.

Dynamic Changes in Erectile Function and Histological Architecture After Intracorporal Injection of Human Placental Stem Cells in a Pelvic Neurovascular Injury Rat Model.

Gu X, Thakker PU, Matz EL, Terlecki RP, Marini FC, Allickson JG, Lue TF, Lin G, Atala A, Yoo JJ, Zhang Y, Jackson JD.

J Sex Med. 2020 Jan 27. pii: S1743-6095(19)31857-0. doi: 10.1016/j.jsxm.2019.12.002. [Epub ahead of print]

PMID:
32001204
11.

Assessment methodologies for extrusion-based bioink printability.

Gillispie G, Prim P, Copus J, Fisher J, Mikos AG, Yoo JJ, Atala A, Lee SJ.

Biofabrication. 2020 Feb 19;12(2):022003. doi: 10.1088/1758-5090/ab6f0d.

PMID:
31972558
12.

Energy Band Gap Investigation of Biomaterials: A Comprehensive Material Approach for Biocompatibility of Medical Electronic Devices.

Shafiee A, Ghadiri E, Kassis J, Williams D, Atala A.

Micromachines (Basel). 2020 Jan 18;11(1). pii: E105. doi: 10.3390/mi11010105.

13.

Re: Selective Targeting of PARP-2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth through Disruption of FOXA1 Function.

Atala A.

J Urol. 2020 Jan 13:101097JU0000000000000732. doi: 10.1097/JU.0000000000000732. [Epub ahead of print] No abstract available.

PMID:
31928478
14.

Re: Epigenetic Loss of AOX1 Expression via EZH2 Leads to Metabolic Deregulations and Promotes Bladder Cancer Progression.

Atala A.

J Urol. 2020 Jan 13:101097JU000000000000073202. doi: 10.1097/JU.0000000000000732.02. [Epub ahead of print] No abstract available.

PMID:
31928477
15.

Re: The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.

Atala A.

J Urol. 2020 Jan 13:101097JU000000000000073201. doi: 10.1097/JU.0000000000000732.01. [Epub ahead of print] No abstract available.

PMID:
31928476
16.

Most-read articles 2019: A year of noteworthy research.

Atala A.

Stem Cells Transl Med. 2020 Jan;9(1):4-5. doi: 10.1002/sctm.19-0437. No abstract available.

17.

Bioprinted Skin Recapitulates Normal Collagen Remodeling in Full-Thickness Wounds.

Jorgensen AM, Varkey M, Gorkun A, Clouse C, Xu L, Chou Z, Murphy SV, Molnar J, Lee SJ, Yoo JJ, Soker S, Atala A.

Tissue Eng Part A. 2020 Jan 28. doi: 10.1089/ten.TEA.2019.0319. [Epub ahead of print]

PMID:
31861970
18.

ECM concentration and cell-mediated traction forces play a role in vascular network assembly in 3D bioprinted tissue.

Zhang G, Varkey M, Wang Z, Xie B, Hou R, Atala A.

Biotechnol Bioeng. 2019 Dec 16. doi: 10.1002/bit.27250. [Epub ahead of print]

PMID:
31840798
19.

Age-related presence of spermatogonia in patients with Klinefelter syndrome: a systematic review and meta-analysis.

Deebel NA, Galdon G, Zarandi NP, Stogner-Underwood K, Howards S, Lovato J, Kogan S, Atala A, Lue Y, Sadri-Ardekani H.

Hum Reprod Update. 2020 Jan 1;26(1):58-72. doi: 10.1093/humupd/dmz038.

PMID:
31822886
20.

Re: Pandemic Fluoroquinolone Resistant Escherichia coli Clone ST1193 Emerged via Simultaneous Homologous Recombinations in 11 Gene Loci.

Atala A.

J Urol. 2020 Mar;203(3):466-467. doi: 10.1097/JU.0000000000000679.02. Epub 2019 Dec 3. No abstract available.

PMID:
31793814
21.

Re: Betaglycan Drives the Mesenchymal Stromal Cell Osteogenic Program and Prostate Cancer-Induced Osteogenesis.

Atala A.

J Urol. 2020 Mar;203(3):465-466. doi: 10.1097/JU.0000000000000679. Epub 2019 Dec 3. No abstract available.

PMID:
31793811
22.

Re: The Androgen Receptor Regulates a Druggable Translational Regulon in Advanced Prostate Cancer.

Atala A.

J Urol. 2020 Mar;203(3):466. doi: 10.1097/JU.0000000000000679.01. Epub 2019 Dec 3. No abstract available.

PMID:
31793808
23.

Efficient myotube formation in 3D bioprinted tissue construct by biochemical and topographical cues.

Kim W, Lee H, Lee J, Atala A, Yoo JJ, Lee SJ, Kim GH.

Biomaterials. 2020 Feb;230:119632. doi: 10.1016/j.biomaterials.2019.119632. Epub 2019 Nov 19.

PMID:
31761486
24.

Multimaterial Dual Gradient Three-Dimensional Printing for Osteogenic Differentiation and Spatial Segregation.

Smith BT, Bittner SM, Watson E, Smoak MM, Diaz-Gomez L, Molina ER, Kim YS, Hudgins CD, Melchiorri AJ, Scott DW, Grande-Allen KJ, Yoo JJ, Atala A, Fisher JP, Mikos AG.

Tissue Eng Part A. 2019 Dec 27. doi: 10.1089/ten.TEA.2019.0204. [Epub ahead of print]

PMID:
31696784
25.

Kidney regeneration approaches for translation.

Yang H, Atala A, Yoo JJ.

World J Urol. 2019 Nov 6. doi: 10.1007/s00345-019-02999-x. [Epub ahead of print]

PMID:
31696256
26.

Opportunities and challenges of translational 3D bioprinting.

Murphy SV, De Coppi P, Atala A.

Nat Biomed Eng. 2019 Nov 6. doi: 10.1038/s41551-019-0471-7. [Epub ahead of print] Review.

PMID:
31695178
27.

Re: Dysregulation of p53-RBM25-Mediated circAMOTL1L Biogenesis Contributes to Prostate Cancer Progression through the circAMOTL1L-miR-193a-5p-Pcdha Pathway.

Atala A.

J Urol. 2020 Feb;203(2):256-257. doi: 10.1097/01.JU.0000613432.22169.0b. Epub 2019 Nov 4. No abstract available.

PMID:
31689165
28.

Re: SORLA Regulates Endosomal Trafficking and Oncogenic Fitness of HER2.

Atala A.

J Urol. 2020 Feb;203(2):255-256. doi: 10.1097/JU.0000000000000634. Epub 2019 Nov 4. No abstract available.

PMID:
31689161
29.

Re: p27 Transcriptionally Coregulates cJun to Drive Programs of Tumor Progression.

Atala A.

J Urol. 2020 Feb;203(2):256. doi: 10.1097/01.JU.0000613428.37416.72. Epub 2019 Nov 4. No abstract available.

PMID:
31689160
30.

Non-Invasive Cell Tracking with Brighter and Red-Transferred Luciferase for Potential Application in Stem Cell Therapy.

Dou L, Matz EL, Gu X, Shu F, Paxton J, Song J, Yoo J, Atala A, Jackson J, Zhang Y.

Cell Transplant. 2019 Dec;28(12):1542-1551. doi: 10.1177/0963689719885078. Epub 2019 Nov 5.

31.

Immune and Cytokine Dysfunction in Cystic Fibrosis.

Leung ST, Khoury O, Barrios C, Ortega VE, Atala A, Murphy SV.

Am J Respir Cell Mol Biol. 2019 Nov;61(5):656-658. doi: 10.1165/rcmb.2018-0361LE. No abstract available.

PMID:
31674827
32.

Bioprinted trachea constructs with patient-matched design, mechanical and biological properties.

Ke D, Yi H, Est-Witte S, George S, Kengla C, Lee SJ, Atala A, Murphy SV.

Biofabrication. 2019 Dec 31;12(1):015022. doi: 10.1088/1758-5090/ab5354.

PMID:
31671417
33.

Towards clinical application of tissue engineering for erectile penile regeneration.

Andrew TW, Kanapathy M, Murugesan L, Muneer A, Kalaskar D, Atala A.

Nat Rev Urol. 2019 Dec;16(12):734-744. doi: 10.1038/s41585-019-0246-7. Epub 2019 Oct 24. Review.

PMID:
31649327
34.

Stromal cells from perinatal and adult sources modulate the inflammatory immune response in vitro by decreasing Th1 cell proliferation and cytokine secretion.

Khoury O, Atala A, Murphy SV.

Stem Cells Transl Med. 2020 Jan;9(1):61-73. doi: 10.1002/sctm.19-0123. Epub 2019 Oct 22.

35.

Re: Distinct Structural Classes of Activating FOXA1 Alterations in Advanced Prostate Cancer.

Atala A.

J Urol. 2020 Jan;203(1):35-36. doi: 10.1097/01.JU.0000604796.77118.90. Epub 2019 Oct 16. No abstract available.

PMID:
31618164
36.

Re: Circulating miR-103a-3p Contributes to Angiotensin II-Induced Renal Inflammation and Fibrosis via a SNRK/NF-κB/p65 Regulatory Axis.

Atala A.

J Urol. 2020 Jan;203(1):34-35. doi: 10.1097/JU.0000000000000592. Epub 2019 Oct 16. No abstract available.

PMID:
31618154
37.

Re: Uropathogenic Escherichia coli Employs both Evasion and Resistance to Subvert Innate Immune-Mediated Zinc Toxicity for Dissemination.

Atala A.

J Urol. 2020 Jan;203(1):35. doi: 10.1097/01.JU.0000604792.92365.f4. Epub 2019 Oct 16. No abstract available.

PMID:
31618147
38.

Nanosensors for therapeutic drug monitoring: implications for transplantation.

Shafiee A, Ghadiri E, Kassis J, Atala A.

Nanomedicine (Lond). 2019 Oct;14(20):2735-2747. doi: 10.2217/nnm-2019-0150. Epub 2019 Oct 16.

PMID:
31617787
39.

Methods to generate tissue-derived constructs for regenerative medicine applications.

Paulo Zambon J, Atala A, Yoo JJ.

Methods. 2019 Oct 10. pii: S1046-2023(18)30445-6. doi: 10.1016/j.ymeth.2019.09.016. [Epub ahead of print] Review.

PMID:
31606388
40.

Re: Urinary Tract Colonization is Enhanced by a Plasmid that Regulates Uropathogenic Acinetobacter baumannii Chromosomal Genes.

Atala A.

J Urol. 2019 Dec;202(6):1100. doi: 10.1097/JU.0000000000000543. Epub 2019 Sep 12. No abstract available.

PMID:
31512972
41.

Re: Bladder Cancer Extracellular Vesicles Drive Tumorigenesis by Inducing the Unfolded Protein Response in Endoplasmic Reticulum of Nonmalignant Cells.

Atala A.

J Urol. 2019 Dec;202(6):1100-1101. doi: 10.1097/01.JU.0000585152.03649.98. Epub 2019 Sep 12. No abstract available.

PMID:
31512971
42.

Re: Communication of Prostate Cancer Cells with Bone Cells via Extracellular Vesicle RNA; a Potential Mechanism of Metastasis.

Atala A.

J Urol. 2019 Dec;202(6):1101. doi: 10.1097/01.JU.0000585156.80777.2f. Epub 2019 Sep 12. No abstract available.

PMID:
31512967
43.

Encapsulation of Mesenchymal Stem Cells in 3D Ovarian Cell Constructs Promotes Stable and Long-Term Hormone Secretion with Improved Physiological Outcomes in a Syngeneic Rat Model.

Sittadjody S, Enck KM, Wells A, Yoo JJ, Atala A, Saul JM, Opara EC.

Ann Biomed Eng. 2020 Mar;48(3):1058-1070. doi: 10.1007/s10439-019-02334-w. Epub 2019 Jul 31.

PMID:
31367915
44.

Re: Recurrent Activating Mutations of PPARγ Associated with Luminal Bladder Tumors.

Atala A.

J Urol. 2019 Nov;202(5):869. doi: 10.1097/01.JU.0000579440.28642.21. Epub 2019 Oct 9. No abstract available.

PMID:
31365313
45.

Re: p27 Transcriptionally Coregulates cJun to Drive Programs of Tumor Progression.

Atala A.

J Urol. 2019 Nov;202(5):868. doi: 10.1097/JU.0000000000000477. Epub 2019 Oct 9. No abstract available.

PMID:
31365310
46.

Re: ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

Atala A.

J Urol. 2019 Nov;202(5):869-870. doi: 10.1097/01.JU.0000579444.36265.f9. Epub 2019 Oct 9. No abstract available.

PMID:
31365309
47.

Amnion membrane hydrogel and amnion membrane powder accelerate wound healing in a full thickness porcine skin wound model.

Murphy SV, Skardal A, Nelson RA Jr, Sunnon K, Reid T, Clouse C, Kock ND, Jackson J, Soker S, Atala A.

Stem Cells Transl Med. 2020 Jan;9(1):80-92. doi: 10.1002/sctm.19-0101. Epub 2019 Jul 21.

48.

Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.

Lyu P, Javidi-Parsijani P, Atala A, Lu B.

Nucleic Acids Res. 2019 Sep 26;47(17):e99. doi: 10.1093/nar/gkz605.

49.

Re: The Proteogenomic Landscape of Curable Prostate Cancer.

Atala A.

J Urol. 2019 Oct;202(4):664. doi: 10.1097/01.JU.0000576980.13730.fe. Epub 2019 Sep 6. No abstract available.

PMID:
31287765
50.

Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance.

Atala A.

J Urol. 2019 Oct;202(4):663. doi: 10.1097/JU.0000000000000434. Epub 2019 Sep 6. No abstract available.

PMID:
31287760

Supplemental Content

Support Center